# Paradigm Biopharmaceuticals Limited (PBIGF)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PBIGF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 80.1K | $ -56.28M | $ 0 | $ 7.50M | $ 3.47M |
| 2025 | $ 52.1K | $ -18.77M | $ -15.99M | $ 5.5K | $ 21.18M |
| 2024 | $ 67.4K | $ -60.06M | $ -62.43M | $ 239.3K | $ 23.81M |
| 2023 | $ 49.6K | $ -55.08M | $ -47.95M | $ 341.7K | $ 53.68M |
| 2022 | $ 90.0K | $ -44.57M | $ -36.57M | $ 616.7K | $ 42.31M |
| 2021 | $ 24.5K | $ -40.93M | $ -41.72M | $ 751.8K | $ 78.27M |
| 2020 | $ -57 | $ -14.84M | $ -12.33M | $ 873.7K | $ 108.18M |
| 2019 | $ 3.68M | $ -19.27M | $ -7.88M | $ 36.6K | $ 82.81M |
| 2018 | $ 3.35M | $ -7.73M | $ -7.52M | $ 36.6K | $ 13.86M |
| 2017 | $ 2.32M | $ -5.44M | $ -5.72M | $ 36.6K | $ 13.39M |
| 2016 | $ 1.68M | $ -3.80M | $ -4.68M | $ 36.6K | $ 11.23M |
| 2015 | $ 0 | $ -2.06M | $ -1.59M | $ 171.8K | $ 609.1K |
| 2014 | $ 0 | $ -309.7K | $ -824.6K | $ 195.8K | $ -151.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.16 |
| Liabilities / Eq | 7.80 |
| Current Ratio | 1.10 |

## Other views

- [Metrics](https://sponda.capital/en/PBIGF.md)
- [Charts](https://sponda.capital/en/PBIGF/charts.md)
- [Compare](https://sponda.capital/en/PBIGF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.